News Analysis To read the headlines, you’d think the verdict was in. On Oct. 26, the Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee recommended the approval of Pfizer-BioNTech’s RNA COVID-19 vaccine for children 5-11, under an Emergency Use Authorization (EUA). On Oct. 29, the FDA issued an emergency authorization based on the committee’s recommendation. Still, a few small steps remain before vaccines reach a kindergarten near you. A Centers for Disease Control and Prevention (CDC) advisory panel needs to carry out their own vote on giving kids the vaccine for COVID-19, the disease caused by the Chinese Communist Party (CCP) virus. CDC Director Rochelle Walensky will then offer her own recommendation after evaluating that panel’s finding. Assuming these decisions go Pfizer’s way, the path would be clear for the widespread vaccination of young children throughout the United States. The Biden administration seems confident that the …